Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Implicit Bioscience

Implicit Bioscience?uq=kzBhZRuG
2002 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Angel LATEST DEAL TYPE
$125K LATEST DEAL AMOUNT
Description

Operator of a clinical-stage drug development company intended to discover drugs for inflammatory and infectious diseases. The company's clinical-stage drug development service develops drugs that modulate the host immune response to disease and it develops small molecule dipeptide oglufanide disodium for community and hospital-acquired infections including those caused by bio-threat agents, enabling doctors to treat inflammatory and infectious diseases.

Formerly Known As
Melmotte
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • James Tower, Suite 235
  • 550 17th Avenue
  • Seattle, WA 98122
  • United States

+1 (206) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Implicit Bioscience’s full profile, request a free trial.

Implicit Bioscience Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Angel (individual) 13-Sep-2017 $125K 00000 Completed Generating Revenue
2. Angel (individual) 15-Sep-2016 00000 00000 Completed Generating Revenue
1. Angel (individual) 16-Nov-2015 $50.8K $50.8K Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Implicit Bioscience Executive Team (7)

Name Title Board
Seat
Contact
Info
Marion Koster Chief Financial Officer and Company Secretary
Garry Redlich Managing Director, Chief Executive Officer, Board Member and Co-Founder
Don Foster Ph.D Chief Scientific Officer
Jim Rottsolk Director and Chairman
Ian Frazer Director & Chairman, Scientific Advisory Board
You’re viewing 5 of 7 executives. Get the full list »

Implicit Bioscience Board Members (9)

Name Representing Role Since Contact
Info
Daniel Syrdal Ph.D Implicit Bioscience Board Member 000 0000
Garry Redlich Implicit Bioscience Managing Director, Chief Executive Officer, Board Member and Co-Founder 000 0000
Ian Frazer Implicit Bioscience Director & Chairman, Scientific Advisory Board 000 0000
James Rottsolk Implicit Bioscience Board Member 000 0000
Jim Rottsolk Implicit Bioscience Director and Chairman 000 0000
You’re viewing 5 of 9 board members. Get the full list »